MDD
Schizophrenia
Bipolar Disorder
Anxiety
PTSD
Hypertension
Diabetes
CKD
Obesity
Alzheimer
NASH/MASH
Eczema
Acne
Psoriasis
Hidradenitis suppurativa
COVID-19
Hepatitis B/C
RSV
FLU
UTIs
• 90% enrollment goal achievement across active trials
• <5% protocol deviation rate
• 100% pre-screened participants documented in CTMS
• 24–48h response time for queries and regulatory requests
• Familiarity with on site, hybrid, and remote visit models
• Over 10 clinical trials completed
• Successful collaborations with more than 5 sponsors and CROs
• High retention and low dropout rates
• Proven capability to enroll hard-to-reach populations
Copyright © 2025 PD Medical Research Service - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.